Merck Drops On Light Q4 Sales, Full-Year Guidance

Merck ( MRK ) is falling Wednesday, after its disappointing fourth-quarter sales and guidance overshadowed better-than-expected earnings.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.